{"skill":{"slug":"lonza","displayName":"Lonza","summary":"Swiss CDMO with $6B+ revenue, advanced biologics and cell/gene therapy manufacturing, key supplier to top 20 pharma including Moderna's COVID-19 vaccine.","tags":{"latest":"1.0.0"},"stats":{"comments":0,"downloads":30,"installsAllTime":0,"installsCurrent":0,"stars":0,"versions":1},"createdAt":1778612768396,"updatedAt":1778613112169},"latestVersion":{"version":"1.0.0","createdAt":1778612768396,"changelog":"Lonza skill v1.0.0 – Initial Release\n\n- Provides an overview of Lonza, a leading Swiss CDMO with $6B+ revenue and critical global pharma partnerships.\n- Covers company history, business model, and major milestones (including key acquisitions and COVID-19 vaccine role).\n- Highlights core competencies such as large-scale biologics manufacturing and advanced cell/gene therapy capabilities.\n- Includes differentiated insights: global footprint, customer relationships, and unique manufacturing site details.\n- Outlines segment structure and key competitive advantages for users researching Lonza or comparing it to peers.","license":"MIT-0"},"metadata":null,"owner":{"handle":"hanxueyuan","userId":"s17eht14r6y7ztwaw37n96ka7583eghn","displayName":"hanxueyuan","image":"https://avatars.githubusercontent.com/u/16717383?v=4"},"moderation":null}